Pre-dialysis serum creatinine as an independent predictor of responsiveness to zinc supplementation among patients on hemodialysis.

Abstract:

BACKGROUND:To investigate whether pre-dialysis level of serum creatinine (SCre) could indicate the responsiveness to zinc supplementation of patients on maintenance hemodialysis (MHD). METHODS:We retrospectively reviewed the results of our previous randomized study of 91 patients who had been on MHD and received zinc supplementation with either zinc acetate hydrate (ZAH; zinc, 50 mg/day) or polaprezinc (PPZ; zinc, 34 mg/day). A late response to zinc supplementation was defined as a serum zinc level of < 80 μg/dL three months after the study began. Patients were divided into two groups: late response (serum zinc level < 80 μg/dL) and early response (serum zinc level ≥ 80 μg/dL). Factors independently associated with a late response to zinc supplementation were determined using inverse probability of treatment weighting (IPTW) multivariate logistic analysis. RESULTS:Of 91 patients, 86 continued to receive zinc supplementation after three months. The mean pre-dialysis SCre level was 10.0 mg/dL. The number of patients with a late response and response to zinc supplementation was 32 and 54, respectively. There was a significant negative correlation between the pre-dialysis SCre and the Δserum zinc change for 3 months. (r = - 0.284, P = 0.008). IPTW multivariate analysis showed that a pre-dialysis SCre level ≥ 10.0 mg/dL (odds ratio, 3.71; 95% confidence interval; 1.24-11.1, P = 0.022) was an independent factor associated with a late response to zinc supplementation. CONCLUSIONS:Pre-dialysis SCre level was independently associated with responsiveness to zinc supplementation after three months in patients on MHD.

journal_name

Clin Exp Nephrol

authors

Okamoto T,Hatakeyama S,Togashi K,Hamaya T,Tanaka Y,Imanishi K,Takashima T,Saitoh F,Suzuki T,Ohyama C

doi

10.1007/s10157-020-01911-x

subject

Has Abstract

pub_date

2020-10-01 00:00:00

pages

955-962

issue

10

eissn

1342-1751

issn

1437-7799

pii

10.1007/s10157-020-01911-x

journal_volume

24

pub_type

杂志文章
  • The Japanese Histologic Classification and T-score in the Oxford Classification system could predict renal outcome in Japanese IgA nephropathy patients.

    abstract:BACKGROUND:The Oxford Classification is utilized globally, but has not been fully validated. In this study, we conducted a comparative analysis between the Oxford Classification and Japanese Histologic Classification (JHC) to predict renal outcome in Japanese patients with IgA nephropathy (IgAN). METHODS:A retrospecti...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-017-1393-x

    authors: Kaihan AB,Yasuda Y,Katsuno T,Kato S,Imaizumi T,Ozeki T,Hishida M,Nagata T,Ando M,Tsuboi N,Maruyama S

    更新日期:2017-12-01 00:00:00

  • Spontaneous remission of persistent severe hematuria in an adolescent with nutcracker syndrome: seven years' observation.

    abstract::A Japanese boy aged 14 years presented with gross hematuria associated with mild proteinuria and was diagnosed as having nutcracker syndrome. Magnetic resonance angiography (MRA) revealed significant compression of the left renal vein between the aorta and the superior mesenteric artery with collaterals. A percutaneou...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-003-0267-6

    authors: Tanaka H,Waga S

    更新日期:2004-03-01 00:00:00

  • Study design and methods for a clinical trial of an oral carbonaceous adsorbent used to prevent the progression of chronic kidney disease (CAP-KD).

    abstract:BACKGROUND:The number of patients with chronic kidney disease (CKD) in Japan is currently rising. Therefore, measures to control the progression of CKD from a predialysis condition to endstage renal failure are urgently required. We are conducting a clinical trial to investigate the efficacy of an oral carbonaceous ads...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-005-0358-7

    authors: Morita S,Fukuhara S,Akizawa T,Asano Y,Kurokawa K

    更新日期:2005-09-01 00:00:00

  • Role of A20/TNFAIP3 deficiency in lupus nephritis in MRL/lpr mice.

    abstract:BACKGROUND:The activation of the nuclear factor-κB (NF-κB) signaling pathway gives rise to inflammation in the pathogenesis of lupus nephritis (LN), with A20 serving as a negative feedback regulator and ubiquitin C‑terminal hydrolase L1 (UCH-L1) acting as a downstream target protein. However, their roles in the mechani...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-019-01826-2

    authors: Sun L,Zou LX,Han YC,Zhu DD,Chen T,Wang J

    更新日期:2020-02-01 00:00:00

  • Renal infarct volume and renal function decline in acute and chronic phases.

    abstract:BACKGROUND:Acute renal infarction (ARI) is a rare disease. ARI causes decline in renal function in both the acute and chronic phases. However, the correlation between the volume of the infarction and degree of renal function decline has not been fully investigated. Therefore, we aimed to examine the relationship betwee...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-017-1399-4

    authors: Kagaya S,Yoshie O,Fukami H,Sato H,Saito A,Takeuchi Y,Matsuda K,Nagasawa T

    更新日期:2017-12-01 00:00:00

  • Aliskiren-associated acute kidney injury in a patient with pre-existing chronic kidney disease and dilated cardiomyopathy.

    abstract::We report a case of acute kidney injury (AKI) caused by a novel direct renin inhibitor, aliskiren. A 43-year-old Japanese man with dilated cardiomyopathy on cardiac resynchronization therapy with defibrillator and chronic kidney disease (CKD) was started on aliskiren in addition to enalapril, carvedilol, furosemide, a...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-011-0566-2

    authors: Yamauchi J,Shibagaki Y,Uehara K,Yasuda T,Kimura K

    更新日期:2012-04-01 00:00:00

  • How to resolve confusion in the clinical setting for the diagnosis of heterozygous COL4A3 or COL4A4 gene variants? Discussion and suggestions from nephrologists.

    abstract::Both thin basement membrane nephropathy (TBMN) and autosomal dominant Alport syndrome (ADAS) are types of hereditary nephritis resulting from heterozygous mutations in COL4A3 or COL4A4 genes. Although TBMN is characterized by hematuria and thinning of the glomerular basement membrane (GBM) with excellent renal prognos...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章,评审

    doi:10.1007/s10157-020-01880-1

    authors: Imafuku A,Nozu K,Sawa N,Nakanishi K,Ubara Y

    更新日期:2020-08-01 00:00:00

  • Improvement of nephrotic syndrome by intensive lipid-lowering therapy in a patient with lipoprotein glomerulopathy.

    abstract::Lipoprotein glomerulopathy (LPG) is a rare hereditary disease characterized by the accumulation of much thrombi material consisting of lipoproteins at the glomerular capillary lumen. Most patients show nephrotic syndrome; nearly half progress to chronic renal failure. Intensive therapy with lipid-lowering agents repor...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-009-0207-1

    authors: Matsunaga A,Furuyama M,Hashimoto T,Toyoda K,Ogino D,Hayasaka K

    更新日期:2009-12-01 00:00:00

  • Rituximab for nephrotic syndrome in children.

    abstract::Idiopathic nephrotic syndrome is the most common chronic glomerular disease in children. At least 20 % of children with this syndrome show frequent relapses and/or steroid dependence during or after immunosuppressive therapies, a condition defined as complicated frequently relapsing/steroid-dependent nephrotic syndrom...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章,评审

    doi:10.1007/s10157-016-1313-5

    authors: Iijima K,Sako M,Nozu K

    更新日期:2017-04-01 00:00:00

  • Uric acid-lowering and renoprotective effects of topiroxostat, a selective xanthine oxidoreductase inhibitor, in patients with diabetic nephropathy and hyperuricemia: a randomized, double-blind, placebo-controlled, parallel-group study (UPWARD study).

    abstract:BACKGROUND:Hyperuricemia is supposed to be an independent risk factor for kidney dysfunction in diabetic patients. We attempted to examine the uric acid-lowering effect and the renoprotective effect of topiroxostat, a selective xanthine oxidoreductase inhibitor, in patients with diabetic nephropathy and hyperuricemia i...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s10157-018-1530-1

    authors: Wada T,Hosoya T,Honda D,Sakamoto R,Narita K,Sasaki T,Okui D,Kimura K

    更新日期:2018-08-01 00:00:00

  • Assessment of tubular reabsorption of phosphate as a surrogate marker for phosphate regulation in chronic kidney disease.

    abstract:BACKGROUND/AIMS:Fibroblast growth factor 23 (FGF23) and soluble α-Klotho are emerging potential biomarkers of phosphorus and vitamin D metabolism which change in concentration in early chronic kidney disease (CKD) in order to maintain normal phosphorus levels. Tubular reabsorption of phosphate (TRP) has been commonly u...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-014-0962-5

    authors: Hong YA,Lim JH,Kim MY,Kim Y,Yang KS,Chung BH,Chung S,Choi BS,Yang CW,Kim YS,Chang YS,Park CW

    更新日期:2015-04-01 00:00:00

  • How long is strict bed rest necessary after renal biopsy?

    abstract:BACKGROUND:No consensus exists on the amount of bed rest required after renal biopsy. Moreover, forced prolonged bed rest can be uncomfortable in patients undergoing renal biopsy. OBJECTIVE:To evaluate whether the length of strict bed rest affects the incidence of pain and other complications after renal biopsy. STUDY...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-009-0206-2

    authors: Ishikawa E,Nomura S,Obe T,Katayama K,Oosugi K,Murata T,Tanoue A,Fujimoto M,Matsuo H,Ito M

    更新日期:2009-12-01 00:00:00

  • Relationship between dietary intake and microalbuminuria: findings from the Takahata study.

    abstract:BACKGROUND:Although several studies have investigated the relationship between dietary nutrient intake and microalbuminuria, no study of an Asian population has been reported. The present study investigates the relationship between dietary intake and microalbuminuria in a general Japanese population. METHODS:We analyz...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-011-0539-5

    authors: Sato M,Hozawa A,Konta T,Shao L,Otani K,Narimatsu H,Sasaki S,Kato T,Kubota I,Yamashita H,Kayama T,Fukao A

    更新日期:2012-02-01 00:00:00

  • Clinical pharmacological study of dotinurad administered to male and female elderly or young subjects.

    abstract:BACKGROUND:Dotinurad is a novel selective urate reabsorption inhibitor (SURI) that selectively inhibits the reabsorption of uric acid in renal tubules and promotes the excretion of uric acid into urine. In this study, the effects of age and gender on the pharmacokinetics (PK), pharmacodynamics (PD), and safety of dotin...

    journal_title:Clinical and experimental nephrology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s10157-019-01836-0

    authors: Nakatani H,Fushimi M,Sasaki T,Okui D,Ohashi T

    更新日期:2020-03-01 00:00:00

  • Cardiorenal syndrome: still not a defined entity.

    abstract::Because of the increasing incidence of cardiac failure and chronic renal failure due to the progressive aging of the population, the extensive application of cardiac interventional techniques, the rising rates of obesity and diabetes mellitus, coexistence of heart failure and renal failure in the same patient are freq...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章,评审

    doi:10.1007/s10157-009-0257-4

    authors: Longhini C,Molino C,Fabbian F

    更新日期:2010-02-01 00:00:00

  • A potentially crucial role of the PKD1 C-terminal tail in renal prognosis.

    abstract:BACKGROUND:Autosomal dominant polycystic disease (ADPKD) often results in renal failure. Recently, allelic influences of PKD1 mutation types on renal survival were extensively investigated. Here, we analyzed integrated influences of PKD1 mutation types and positions on renal survival. METHODS:We included 338 (82 pedig...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s10157-017-1477-7

    authors: Higashihara E,Horie S,Kinoshita M,Harris PC,Okegawa T,Tanbo M,Hara H,Yamaguchi T,Shigemori K,Kawano H,Miyazaki I,Kaname S,Nutahara K

    更新日期:2018-04-01 00:00:00

  • Nicorandil suppresses urinary protein excretion and activates eNOS in Dahl salt-sensitive hypertensive rats.

    abstract:BACKGROUND:Hypertension is a risk factor common to both chronic kidney disease and cardiovascular disease. Nicorandil is widely used for the treatment of angina. We investigated the benefits of nicorandil with respect to renal dysfunction in Dahl salt-sensitive hypertensive (DS) rats. METHOD:DS rats were fed a high-sa...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-014-0998-6

    authors: Tashiro Y,Yogo K,Serizawa K,Endo K

    更新日期:2015-06-01 00:00:00

  • A case of angiomyolipoma of the renal sinus.

    abstract::The case of a 63-year-old woman with a relatively rapidly growing angiomyolipoma (AML) originating from the right renal sinus is presented. The tumor had enlarged to more than fivefold in volume (7.4 × 6.7 × 10.1 cm) in the 7 years following its detection (5.6 × 3.4 × 4.6 cm) and had significantly pushed aside the duo...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-011-0519-9

    authors: Shirotake S,Yoshimura I,Kosaka T,Matsuzaki S

    更新日期:2011-12-01 00:00:00

  • Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR).

    abstract:BACKGROUND AND OBJECTIVES:Data regarding renal disease in the elderly (age ≥65 years old) and very elderly (age ≥80 years old) Japanese are extremely limited. The aim of this study was to examine the causes of renal disease and their clinical presentations in elderly patients who underwent renal biopsy. DESIGN, SETTIN...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-012-0673-8

    authors: Yokoyama H,Sugiyama H,Sato H,Taguchi T,Nagata M,Matsuo S,Makino H,Watanabe T,Saito T,Kiyohara Y,Nishi S,Iida H,Morozumi K,Fukatsu A,Sasaki T,Tsuruya K,Kohda Y,Higuchi M,Kiyomoto H,Goto S,Hattori M,Hataya H,Kag

    更新日期:2012-12-01 00:00:00

  • Tubulointerstitial nephritis without glomerular lesions in three patients with myeloperoxidase-ANCA-associated vasculitis.

    abstract:BACKGROUND:Myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis frequently induces crescentic glomerulonephritis. However, a few cases have so far been reported to have only tubulointerstitial (TI) nephritis without any apparent glomerular lesions. We recently treated three similar cases...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-009-0200-8

    authors: Nakabayashi K,Sumiishi A,Sano K,Fujioka Y,Yamada A,Karube M,Koji H,Arimura Y,Nagasawa T

    更新日期:2009-12-01 00:00:00

  • Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment.

    abstract:BACKGROUND:The present study was conducted to clarify the clinical risk factors related to the development of encapsulating peritoneal sclerosis (EPS), which is one of the most serious complications in patients undergoing peritoneal dialysis (PD). METHODS:The records of 78 patients with a history of PD treatment, incl...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-005-0349-8

    authors: Yamamoto R,Otsuka Y,Nakayama M,Maruyama Y,Katoh N,Ikeda M,Yamamoto H,Yokoyama K,Kawaguchi Y,Matsushima M

    更新日期:2005-06-01 00:00:00

  • IgA nephropathy associated with leukemia and lymphoma: report of two cases.

    abstract::IgA nephropathy (IgAN) associated with leukemia and lymphoma has not, to our knowledge, been reported in children. Two children suffering from these diseases are described here. One patient developed IgAN at the end of 5 years' chemotherapy for acute lymphocytic leukemia. The other had microscopic hematuria 3 years be...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-007-0009-2

    authors: Motoyama O,Kojima Y,Ohara A,Tsukimoto I,Ishikawa Y,Iitaka K

    更新日期:2008-04-01 00:00:00

  • Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese.

    abstract:BACKGROUND:Recent studies have suggested that assessments of serum antibodies against M-type phospholipase A2 receptor (PLA2R) and the glomerular expression of PLA2R antigen in biopsy specimens are useful for the diagnosis of primary membranous nephropathy (MN). In this study, we assessed both of them and investigated ...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-014-1064-0

    authors: Hayashi N,Akiyama S,Okuyama H,Matsui Y,Adachi H,Yamaya H,Maruyama S,Imai E,Matsuo S,Yokoyama H

    更新日期:2015-10-01 00:00:00

  • Correction of hyponatremia and osmotic demyelinating syndrome: have we neglected to think intracellularly?

    abstract:BACKGROUND:Osmotic demyelination syndrome (ODS) is a complication generally associated with overly rapid correction of hyponatremia. Traditionally, nephrologists have been trained to focus solely on limiting the correction rate. However, there is accumulating evidence to suggest that the prevention of ODS is beyond ach...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章,评审

    doi:10.1007/s10157-014-1021-y

    authors: Pham PM,Pham PA,Pham SV,Pham PT,Pham PT,Pham PC

    更新日期:2015-06-01 00:00:00

  • Severe metabolic acidosis and hypokalemia in a patient with enterovesical fistula.

    abstract::We report a case of a 59-year-old woman who had severe metabolic acidosis and hypokalemia due to an enterovesical fistula. The patient came to our hospital complaining of systemic weakness and numbness of the fingers. She was found to have hyperchloremic metabolic acidosis (arterial bicarbonate, 2.8 mEq/l) and hypokal...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-007-0475-6

    authors: Murakami K,Tomita M,Kawamura N,Hasegawa M,Nabeshima K,Hiki Y,Sugiyama S

    更新日期:2007-09-01 00:00:00

  • Involvement of CD11b+ GR-1 low cells in autoimmune disorder in MRL-Fas lpr mouse.

    abstract:OBJECTIVE:Myeloid-derived suppressor cells (MDSCs) have been identified as immunosuppressive cells in tumor-related inflammation. However, the pathogenesis of MDSCs for autoimmune disease has not been investigated as yet. The aim of this study was to address whether MDSCs contribute to autoimmune organ injury in lupus-...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-010-0309-9

    authors: Iwata Y,Furuichi K,Kitagawa K,Hara A,Okumura T,Kokubo S,Shimizu K,Sakai N,Sagara A,Kurokawa Y,Ueha S,Matsushima K,Kaneko S,Wada T

    更新日期:2010-10-01 00:00:00

  • Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.

    abstract:BACKGROUND:In 2013, eculizumab was approved for treatment of the atypical hemolytic-uremic syndrome (aHUS) in Japan, which was defined as a thrombotic microangiopathy (TMA) excluding Shiga toxin-producing Escherichia coli-HUS and thrombotic thrombocytopenic purpura. Simultaneously, post-marketing surveillance was start...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-018-1610-2

    authors: Ito S,Hidaka Y,Inoue N,Kaname S,Kato H,Matsumoto M,Miyakawa Y,Mizuno M,Okada H,Shimono A,Matsuda T,Maruyama S,Fujimura Y,Nangaku M,Kagami S

    更新日期:2019-01-01 00:00:00

  • Dual myeloperoxidase-antineutrophil cytoplasmic antibody- and antiglomerular basement membrane antibody-positive cases associated with prior pulmonary fibrosis: a report of four cases.

    abstract:BACKGROUND:Both myeloperoxidase-associated antineutrophil cytoplasmic antibody (MPO-ANCA) and antiglomerular basement membrane antibody (anti-GBM Ab) positivity have been demonstrated in patients with rapidly progressive glomerulonephritis (RPGN), either with or without pulmonary hemorrhage; however, the implications o...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-010-0390-0

    authors: Nakabayashi K,Fujioka Y,Nagasawa T,Kimura T,Kojima K,Arimura Y,Yamada A

    更新日期:2011-04-01 00:00:00

  • Profiling of kidney vascular endothelial cell plasma membrane proteins by liquid chromatography-tandem mass spectrometry.

    abstract:BACKGROUND:Vascular endothelial cells (VECs) play crucial roles in physiological and pathologic conditions in tissues and organs. Most of these roles are related to VEC plasma membrane proteins. In the kidney, VECs are closely associated with structures and functions; however, plasma membrane proteins in kidney VECs re...

    journal_title:Clinical and experimental nephrology

    pub_type: 杂志文章

    doi:10.1007/s10157-012-0708-1

    authors: Liu Z,Xu B,Nameta M,Zhang Y,Magdeldin S,Yoshida Y,Yamamoto K,Fujinaka H,Yaoita E,Tasaki M,Nakagawa Y,Saito K,Takahashi K,Yamamoto T

    更新日期:2013-06-01 00:00:00

  • A clinical pharmacology study of the novel, selective urate reabsorption inhibitor dotinurad in outpatients.

    abstract:BACKGROUND:Dotinurad is a novel, selective urate reabsorption inhibitor (SURI), which reduces serum uric acid levels by selective inhibition of the urate transporter 1 (URAT1). The Japanese guideline for the management of hyperuricemia and gout recommends that drug selection should be based on classification of hyperur...

    journal_title:Clinical and experimental nephrology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1007/s10157-020-01857-0

    authors: Hosoya T,Furuno K,Kanda S

    更新日期:2020-03-01 00:00:00